Legal & General Group PLC Relay Therapeutics, Inc. Transaction History

Legal & General Group PLC

$368 Billion
Q4 2024

A detailed history of Legal & General Group PLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 124,886 shares of RLAY stock, worth $405,879. This represents 0.0% of its overall portfolio holdings.

Number of Shares

124,886

Previous 136,115 8.25%

Holding current value

$405,879

Previous $963,000 46.63%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$4.12 - $6.8 $46,263 - $76,357	-11,229 Reduced 8.25%	124,886 $514,000
Q3 2024 Feb 28, 2025	SELL	$6.23 - $9.51 $9,899 - $15,111	-1,589 Reduced 1.27%	123,297 $872,000
Q3 2024 Nov 14, 2024	BUY	$6.23 - $9.51 $221,108 - $337,519	35,491 Added 35.27%	136,115 $963,000
Q2 2024 Aug 14, 2024	BUY	$5.9 - $8.02 $79,868 - $108,566	13,537 Added 15.54%	100,624 $656,000
Q1 2024 May 14, 2024	BUY	$7.5 - $12.07 $84,660 - $136,246	11,288 Added 14.89%	87,087 $722,000
Q3 2023 Nov 14, 2023	SELL	$8.24 - $12.97 $6,995 - $11,011	-849 Reduced 1.11%	75,799 $637,000
Q2 2023 Aug 14, 2023	BUY	$9.99 - $18.27 $15,864 - $29,012	1,588 Added 2.12%	76,648 $962,000
Q1 2023 May 15, 2023	BUY	$15.0 - $22.76 $190,890 - $289,643	12,726 Added 20.42%	75,060 $1.24 Million
Q4 2022 Feb 14, 2023	SELL	$14.16 - $24.02 $12,503 - $21,209	-883 Reduced 1.4%	62,334 $931,000
Q3 2022 Nov 14, 2022	BUY	$18.07 - $31.37 $47,704 - $82,816	2,640 Added 4.36%	63,217 $1.41 Million
Q2 2022 Aug 22, 2022	BUY	$13.31 - $34.88 $126,804 - $332,301	9,527 Added 18.66%	60,577 $1.02 Million
Q1 2022 May 16, 2022	BUY	$20.26 - $32.36 $7,820 - $12,490	386 Added 0.76%	51,050 $1.53 Million
Q4 2021 Feb 14, 2022	BUY	$26.0 - $37.03 $289,146 - $411,810	11,121 Added 28.12%	50,664 $1.56 Million
Q3 2021 Nov 15, 2021	BUY	$29.75 - $37.99 $188,079 - $240,172	6,322 Added 19.03%	39,543 $1.25 Million
Q2 2021 Aug 12, 2021	BUY	$27.5 - $38.19 $203,307 - $282,338	7,393 Added 28.62%	33,221 $1.22 Million
Q1 2021 May 17, 2021	BUY	$32.52 - $61.53 $395,345 - $748,020	12,157 Added 88.93%	25,828 $893,000
Q4 2020 Feb 12, 2021	SELL	$35.51 - $54.03 $833,100 - $1.27 Million	-23,461 Reduced 63.18%	13,671 $568,000
Q3 2020 Nov 13, 2020	BUY	$32.81 - $45.1 $1.22 Million - $1.67 Million	37,132 New	37,132 $1.58 Million

Others Institutions Holding RLAY

# of Institutions

207

Shares Held

159M

Call Options Held

100K

Put Options Held

26.8K

View Full List

About Relay Therapeutics, Inc.

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $391M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

More about RLAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Relay Therapeutics, Inc. Transaction History